Tore Godal on the elusive malaria vaccine

News February 22, 2010

The Norwegian veteran of global health policy, the doctor and government advisor Tore Godal, reflects on the promise and possible pitfalls of using a so-called AMC approach to trigger the development of a vaccine for malaria.

Without competition among firms, he says, an AMC will not work.

Tore Godal, Special Advisor at the Norwegian Ministry of Foreign Affairs.

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.